Snyder Capital Management »

Peregrine Pharmaceuticals shares owned by Snyder Capital Management

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Snyder Capital Management from 13F filings

Historical chart of Snyder Capital Management investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Snyder Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Snyder Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $21M 2.2M 9.44
2023-06-30 $30M 2.2M 13.97
2023-03-31 $32M 1.7M 18.76
2022-12-31 $27M 2.0M 13.77
2022-09-30 $38M 2.0M 19.12
2022-06-30 $25M 1.6M 15.26
2022-03-31 $34M 1.7M 20.37
2021-12-31 $50M 1.7M 29.18
2021-09-30 $38M 1.8M 21.57
2021-06-30 $46M 1.8M 25.65
2021-03-31 $40M 2.2M 18.23
2020-12-31 $29M 2.5M 11.54
2020-09-30 $18M 2.3M 7.62
2020-06-30 $15M 2.3M 6.57
2020-03-31 $12M 2.3M 5.11
2019-12-31 $17M 2.2M 7.67
2019-09-30 $12M 2.3M 5.30
2019-06-30 $13M 2.2M 5.60
2019-03-31 $10M 2.4M 4.25
2018-12-31 $8.6M 2.1M 4.10
2018-09-30 $13M 1.9M 6.86